Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04565496
Title Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients (PEM-PRO)
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors IRCCS San Raffaele
Indications

prostate cancer

Therapies

Pembrolizumab

Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.